Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-001335
Filing Date
2025-03-04
Accepted
2025-03-04 17:58:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 12794
  Complete submission text file 0000902664-25-001335.txt   14847
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Subject) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83932 | Film No.: 25707072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A